Eli Lilly plans $700 million Institute for Genetic Medicine in Boston Seaport

Pharmaceutical giant Eli Lilly on Tuesday announced plans to make a major investment and establish an Institute for Genetic Medicine in Boston.

The Indianapolis-based company announced that it plans to invest approximately $700 million to establish the facility in the Boston Seaport.